Nutrition in Alzheimer's disease: a review of an underappreciated pathophysiological mechanism
- PMID: 37058185
- DOI: 10.1007/s11427-022-2276-6
Nutrition in Alzheimer's disease: a review of an underappreciated pathophysiological mechanism
Abstract
Alzheimer's disease (AD) is the leading cause of dementia in older individuals and is an escalating challenge to global public health. Pharmacy therapy of AD is one of the well-funded areas; however, little progress has been made due to the complex pathogenesis. Recent evidence has demonstrated that modifying risk factors and lifestyle may prevent or delay the incidence of AD by 40%, which suggests that the management should pivot from single pharmacotherapy toward a multipronged approach because AD is a complex and multifaceted disease. Recently, the gut-microbiota-brain axis has gained tremendous traction in the pathogenesis of AD through bidirectional communication with multiple neural, immune, and metabolic pathways, providing new insights into novel therapeutic strategies. Dietary nutrition is an important and profound environmental factor that influences the composition and function of the microbiota. The Nutrition for Dementia Prevention Working Group recently found that dietary nutrition can affect cognition in AD-related dementia directly or indirectly through complex interactions of behavioral, genetic, systemic, and brain factors. Thus, considering the multiple etiologies of AD, nutrition represents a multidimensional factor that has a profound effect on AD onset and development. However, mechanistically, the effect of nutrition on AD is uncertain; therefore, optimal strategies or the timing of nutritional intervention to prevent or treat AD has not been established.Thus, this review summarizes the current state of knowledge concerning nutritional disorders, AD patient and caregiver burden, and the roles of nutrition in the pathophysiology of AD. We aim to emphasize knowledge gaps to provide direction for future research and to establish optimal nutrition-based intervention strategies for AD.
Keywords: Alzheimer’s disease; brain-gut axis; diet; metabolism; nutrition; pathogenesis.
© 2023. Science China Press.
Similar articles
-
Diet-Microbiota-Brain Axis in Alzheimer's Disease.Ann Nutr Metab. 2021;77 Suppl 2(Suppl 2):21-27. doi: 10.1159/000515700. Epub 2021 Apr 27. Ann Nutr Metab. 2021. PMID: 33906194 Free PMC article. Review.
-
Nutrition: A non-negligible factor in the pathogenesis and treatment of Alzheimer's disease.Alzheimers Dement. 2025 Feb;21(2):e14547. doi: 10.1002/alz.14547. Epub 2025 Jan 27. Alzheimers Dement. 2025. PMID: 39868840 Free PMC article. Review.
-
New Perspectives on Alzheimer's Disease and Nutrition.J Alzheimers Dis. 2015;46(4):1111-27. doi: 10.3233/JAD-150084. J Alzheimers Dis. 2015. PMID: 26402637 Review.
-
Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 2;106:110112. doi: 10.1016/j.pnpbp.2020.110112. Epub 2020 Sep 16. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 32949638 Review.
-
Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.Life Sci. 2021 Jan 1;264:118627. doi: 10.1016/j.lfs.2020.118627. Epub 2020 Oct 22. Life Sci. 2021. PMID: 33169684 Review.
Cited by
-
Malnutrition exacerbating neuropsychiatric symptoms on the Alzheimer's continuum is relevant to the cAMP signaling pathway: Human and mouse studies.Alzheimers Dement. 2025 Feb;21(2):e14506. doi: 10.1002/alz.14506. Epub 2025 Jan 27. Alzheimers Dement. 2025. PMID: 39868480 Free PMC article.
-
The microbiome's influence on obesity: mechanisms and therapeutic potential.Sci China Life Sci. 2025 Mar;68(3):657-672. doi: 10.1007/s11427-024-2759-3. Epub 2024 Nov 28. Sci China Life Sci. 2025. PMID: 39617855 Review.
-
The Protective Effect of Mangiferin on Formaldehyde-Induced HT22 Cell Damage and Cognitive Impairment.Pharmaceutics. 2023 May 23;15(6):1568. doi: 10.3390/pharmaceutics15061568. Pharmaceutics. 2023. PMID: 37376018 Free PMC article.
-
Relationship between Alzheimer's Disease and Type 2 Diabetes: Critical Review On Cellular and Molecular Common Pathogenic Mechanisms.Curr Alzheimer Res. 2025;22(2):92-122. doi: 10.2174/0115672050375461250325074826. Curr Alzheimer Res. 2025. PMID: 40231540 Review.
-
Prevalence and correlation of sarcopenia with Alzheimer's disease: A systematic review and meta-analysis.PLoS One. 2025 Mar 3;20(3):e0318920. doi: 10.1371/journal.pone.0318920. eCollection 2025. PLoS One. 2025. PMID: 40029915 Free PMC article.
References
-
- Aarsland, D. (2020). Epidemiology and pathophysiology of dementia-related psychosis. J Clin Psychiatry 81.
-
- Adeyemi, O.S., Awakan, O.J., Afolabi, L.B., Rotimi, D.E., Oluwayemi, E., Otuechere, C.A., Ibraheem, O., Elebiyo, T.C., Alejolowo, O., and Arowolo, A.T. (2021). Hypoxia and the kynurenine pathway: implications and therapeutic prospects in Alzheimer’s disease. Oxid Med Cell Longev 2021, 5522981. - PubMed - PMC - DOI
-
- ADI. (2018). World Alzheimer Report 2018: the state of the art of dementia research: new frontiers. London: Alzheimer’s Disease International..
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical